About SMT
SMT is a company based in Surat (India) founded in 1998. It operates as a Direct-to-Consumer (D2C), and Professional Services. SMT has raised $57.22 million across 4 funding rounds from investors including SBI Mutual Fund, Kotak Mahindra Bank and Plutus. The company has 1,090 employees as of February 08, 2025. SMT has completed 2 acquisitions, including Vascular Concepts and Zarek. SMT offers products and services including Supraflex Cruz, Hydra Aortic Valve, Cocoon Septal Occluder, and Renofit. SMT operates in a competitive market with competitors including InspireMD, Vesper Medical, Endospan, Biosensors International and Veryan Medical, among others.
- Headquarter Surat, India
- Employees 1090 as on 08 Feb, 2025
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sahajanand Medical Technologies Ltd.
- Date of Incorporation 18 Oct, 2001
- Jurisdiction Surat, Gujarat, India
-
Annual Revenue
$106.25 M (USD)13.55as on Mar 31, 2024
-
Net Profit
$-859.11 K (USD)-161.62as on Mar 31, 2024
-
EBITDA
$12.88 M (USD)-3.01as on Mar 31, 2024
-
Total Equity Funding
$57.22 M (USD)
in 4 rounds
-
Latest Funding Round
$20.87 M (USD), Unspecified
Jan 19, 2023
-
Investors
SBI Mutual Fund
& 78 more
-
Employee Count
1090
as on Feb 08, 2025
-
Investments & Acquisitions
Vascular Concepts
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SMT
SMT offers a comprehensive portfolio of products and services, including Supraflex Cruz, Hydra Aortic Valve, Cocoon Septal Occluder, and Renofit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced coronary stent used for arterial blockages treatment.
Valve designed for treating severe aortic stenosis conditions.
Device used to close atrial septal heart defects.
Balloon expandable stent for renal and biliary issues.
Funding Insights of SMT
SMT has successfully raised a total of $57.22M across 4 strategic funding rounds. The most recent funding activity was a Unspecified round of $20.87 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Unspecified — $20.9M
-
First Round
First Round
(20 Mar 2009)
- Investors Count 79
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Unspecified - SMT | Valuation | Kotak Mahindra Bank |
|
| Jan, 2022 | Amount | Unspecified - SMT | Valuation | SBI Mutual Fund | |
| Dec, 2016 | Amount | Unspecified - SMT | Valuation | Samara Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SMT
SMT has secured backing from 79 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include SBI Mutual Fund, Kotak Mahindra Bank and Plutus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed across multiple sectors.
|
Founded Year | Domain | Location | |
|
Commercial banking services are offered to corporate and retail customers.
|
Founded Year | Domain | Location | |
|
Provides mutual funds management and financial advisory services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SMT
SMT has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Vascular Concepts and Zarek. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Coronary and peripheral stents are manufactured for arterial disease treatments.
|
1992 | ||||
|
-
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SMT
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Smt Comparisons
Competitors of SMT
SMT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InspireMD, Vesper Medical, Endospan, Biosensors International and Veryan Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Proprietary stent systems with bio-stable mesh are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Venous stent system is developed for deep vein disease treatment.
|
|
| domain | founded_year | HQ Location |
Endovascular stent graft systems for aortic aneurysm repair are developed.
|
|
| domain | founded_year | HQ Location |
Products for interventional cardiology and critical care procedures
|
|
| domain | founded_year | HQ Location |
Three-dimensional vascular stents for peripheral vascular disease are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Smt
Frequently Asked Questions about SMT
When was SMT founded?
SMT was founded in 1998 and raised its 1st funding round 11 years after it was founded.
Where is SMT located?
SMT is headquartered in Surat, India. It is registered at Surat, Gujarat, India.
Who is the current CEO of SMT?
Bhargav Kotadia is the current CEO of SMT.
Is SMT a funded company?
SMT is a funded company, having raised a total of $57.22M across 4 funding rounds to date. The company's 1st funding round was a Unspecified of $25.22M, raised on Mar 20, 2009.
How many employees does SMT have?
As of Feb 08, 2025, the latest employee count at SMT is 1,090.
What is the annual revenue of SMT?
Annual revenue of SMT is $106.25M as on Mar 31, 2024.
What does SMT do?
SMT, officially known as Sahajanand Medical Technologies Ltd., is engaged in the development and manufacturing of minimally invasive cardiovascular devices. The company operates within the healthcare sector, focusing on coronary stents, structural heart devices, and peripheral intervention solutions. Products such as Supraflex Cruz and Hydra Aortic Valve are designed to address conditions like coronary artery disease and aortic stenosis. With a global presence, SMT is committed to advancing patient care through innovative medical solutions across multiple regions.
Who are the top competitors of SMT?
SMT's top competitors include InspireMD, Endospan and Vesper Medical.
What products or services does SMT offer?
SMT offers Supraflex Cruz, Hydra Aortic Valve, Cocoon Septal Occluder, and Renofit.
How many acquisitions has SMT made?
SMT has made 2 acquisitions, including Vascular Concepts, and Zarek.
Who are SMT's investors?
SMT has 79 investors. Key investors include SBI Mutual Fund, Kotak Mahindra Bank, Plutus, Madhuri Madhusudan Kela, and Samara Capital.
What is SMT's valuation?
The valuation of SMT is $329.92M as of Jan 2023.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.